BENSALEM, Pa. , Dec. 1, 2025 /PRNewswire/ -- The Law Offices of Howard G.

LOS ANGELES , Dec. 1, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against WPP plc ("WPP" or the "Company") (NYSE: WPP). IF YOU SUFFERED A LOSS ON YOUR WPP INVESTMENTS, CLICK HERE BEFORE DECEMBER 8, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was associated with a reduction in MRI measured neuroinflammation compared to placebo across multiple key brain regions, including key Alzheimer's disease-associated regions, most notably in the hippocampus Reduction in hippocampal neuroinflammation, measured using MRI assessed free water, correlated strongly with preservation of hippocampal volume and with clinical outcomes Findings suggest a sustained anti-inflammatory effect of laromestrocel, reinforcing its proposed mechanism of action in the treatment of mild Alzheimer's disease MIAMI, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical …

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Synopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS) and certain of its officers.

LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 16, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”).

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Stride, Inc. (“Stride” or “the Company”) (NYSE: LRN) and certain of its officers.

LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 12, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Freeport-McMoran Inc. (“Freeport” or the “Company”) (NYSE: FCX) securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”).

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: SKYE) and certain of its officers.

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) and certain of its officers.

Appointment supports Life360's leadership team as the company scales globally and continues to deliver peace of mind to families worldwide. Appointment supports Life360's leadership team as the company scales globally and continues to deliver peace of mind to families worldwide.

LOS GATOS, Calif. , Dec. 1, 2025 /PRNewswire/ -- Netflix, Inc. (Nasdaq: NFLX) announced today that Ted Sarandos, Co-CEO, will participate in a fireside discussion at the UBS Global TMT Conference on Monday, December 8, 2025.

BENSALEM, Pa. , Dec. 1, 2025 /PRNewswire/ -- The Law Offices of Howard G.

Synopsys Inc (NASDAQ:SNPS, XETRA:SYP) shares added more than 3% on Monday to trade at about $433 after Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) announced a significant investment and expanded collaboration with the engineering software company. Nvidia is acquiring approximately $2 billion of Synopsys common stock through a private placement at $414.79 per share, making Nvidia one of Synopsys' largest shareholders.

AVO leverages global scale, strong sourcing and rising demand to strengthen its role in the expanding avocado market.

Chip design software maker Synopsys is the latest tech firm to see its stock surge on an AI partnership with Nvidia.

Grab stands out as a stock for leading Southeast Asia exposure among US-listed stocks. Record GMV growth despite a dominant market share shows the core business is still expanding, not saturated. Financial Segment Adjusted EBITDA is expected to hit break even in 2026 with rapid loan book acceleration.

DraftKings is ramping up AI investment as other spend eases, positioning automation to cut costs in 2026 and shape its next margin cycle.

While the financial world has been captivated by the volatility of cryptocurrency and the steady march of gold, a different asset has quietly taken the lead in 2025. Silver, often dismissed as the volatile younger sibling in the precious metals family, is beginning to shed its reputation as the poor man's gold.

Nvidia on Monday announced it has purchased $2 billion of Synopsys' common stock as part of a strategic partnership to accelerate computing and artificial intelligence engineering solutions. Nvidia said it purchased Synopsys' stock at $414.79 per share.